Casdin Capital, LLC Standard Biotools Inc. Transaction History
Casdin Capital, LLC
- $1.15 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 63,959,677 shares of LAB stock, worth $123 Million. This represents 9.8% of its overall portfolio holdings.
Number of Shares
63,959,677
Previous 61,907,605
3.31%
Holding current value
$123 Million
Previous $168 Million
32.52%
% of portfolio
9.8%
Previous 13.55%
Shares
3 transactions
Others Institutions Holding LAB
# of Institutions
148Shares Held
269MCall Options Held
422KPut Options Held
40.7K-
Viking Global Investors LP58.7MShares$113 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$41.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$30.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$24.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.7MShares$24.3 Million0.2% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $151M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...